APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oxycodone Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchOxycodone Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oxycodone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Oxycodone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oxycodone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oxycodone market include Teva Pharmaceuticals, Sun Pharmaceutical (Chattem Chemicals), Sanofi, Johnson & Johnson, Mylan, Pfizer, Purdue Pharma, Mallinckrodt and Indivior, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxycodone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxycodone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxycodone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxycodone market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxycodone Segment by Company

Teva Pharmaceuticals

Sun Pharmaceutical (Chattem Chemicals)

Sanofi

Johnson & Johnson

Mylan

Pfizer

Purdue Pharma

Mallinckrodt

Indivior

Impax Laboratories

Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

Endo International

Oxycodone Segment by Type

Long Acting Oxycodone

Short Acting Oxycodone

Oxycodone Segment by Application

Hospital Pharmacies

Retail Pharmacies

Others

Oxycodone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oxycodone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oxycodone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oxycodone significant trends, drivers, influence factors in global and regions.

6. To analyze Oxycodone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxycodone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxycodone industry.

Chapter 3: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oxycodone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oxycodone Industry Trends Table 2. Oxycodone Industry Drivers Table 3. Oxycodone Industry Opportunities and Challenges Table 4. Oxycodone Industry Restraints Table 5. Global Oxycodone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oxycodone Revenue Share by Company (2021-2026) Table 7. Global Oxycodone Sales Volume by Company (k units) & (2021-2026) Table 8. Global Oxycodone Sales Volume Share by Company (2021-2026) Table 9. Global Oxycodone Average Price (US$/unit) of Company (2021-2026) Table 10. Global Oxycodone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oxycodone Key Company Manufacturing Base & Headquarters Table 12. Global Oxycodone Company, Product Type & Application Table 13. Global Oxycodone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxycodone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Long Acting Oxycodone Table 18. Significant Companies of Short Acting Oxycodone Table 19. Global Oxycodone Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Oxycodone Sales Volume by Type (2021-2026) & (k units) Table 21. Global Oxycodone Sales Volume by Type (2027-2032) & (k units) Table 22. Global Oxycodone Sales Volume Share by Type (2021-2026) Table 23. Global Oxycodone Sales Volume Share by Type (2027-2032) Table 24. Global Oxycodone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oxycodone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oxycodone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oxycodone Sales Value Share by Type (2021-2026) Table 28. Global Oxycodone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Others Table 32. Global Oxycodone Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Oxycodone Sales Volume by Application (2021-2026) & (k units) Table 34. Global Oxycodone Sales Volume by Application (2027-2032) & (k units) Table 35. Global Oxycodone Sales Volume Share by Application (2021-2026) Table 36. Global Oxycodone Sales Volume Share by Application (2027-2032) Table 37. Global Oxycodone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Oxycodone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Oxycodone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Oxycodone Sales Value Share by Application (2021-2026) Table 41. Global Oxycodone Sales Value Share by Application (2027-2032) Table 42. Global Oxycodone Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Oxycodone Sales by Region (2021-2026) & (k units) Table 44. Global Oxycodone Sales Market Share by Region (2021-2026) Table 45. Global Oxycodone Sales by Region (2027-2032) & (k units) Table 46. Global Oxycodone Sales Market Share by Region (2027-2032) Table 47. Global Oxycodone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Oxycodone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Oxycodone Sales Value Share by Region (2021-2026) Table 50. Global Oxycodone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Oxycodone Sales Value Share by Region (2027-2032) Table 52. Global Oxycodone Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Oxycodone Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Oxycodone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Oxycodone Sales by Country (2021-2026) & (k units) Table 57. Global Oxycodone Sales Market Share by Country (2021-2026) Table 58. Global Oxycodone Sales by Country (2027-2032) & (k units) Table 59. Global Oxycodone Sales Market Share by Country (2027-2032) Table 60. Global Oxycodone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Oxycodone Sales Value Market Share by Country (2021-2026) Table 62. Global Oxycodone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Oxycodone Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceuticals Company Information Table 65. Teva Pharmaceuticals Business Overview Table 66. Teva Pharmaceuticals Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceuticals Oxycodone Product Portfolio Table 68. Teva Pharmaceuticals Recent Development Table 69. Sun Pharmaceutical (Chattem Chemicals) Company Information Table 70. Sun Pharmaceutical (Chattem Chemicals) Business Overview Table 71. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio Table 73. Sun Pharmaceutical (Chattem Chemicals) Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Sanofi Oxycodone Product Portfolio Table 78. Sanofi Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Oxycodone Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Mylan Company Information Table 85. Mylan Business Overview Table 86. Mylan Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Mylan Oxycodone Product Portfolio Table 88. Mylan Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Pfizer Oxycodone Product Portfolio Table 93. Pfizer Recent Development Table 94. Purdue Pharma Company Information Table 95. Purdue Pharma Business Overview Table 96. Purdue Pharma Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Purdue Pharma Oxycodone Product Portfolio Table 98. Purdue Pharma Recent Development Table 99. Mallinckrodt Company Information Table 100. Mallinckrodt Business Overview Table 101. Mallinckrodt Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Mallinckrodt Oxycodone Product Portfolio Table 103. Mallinckrodt Recent Development Table 104. Indivior Company Information Table 105. Indivior Business Overview Table 106. Indivior Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Indivior Oxycodone Product Portfolio Table 108. Indivior Recent Development Table 109. Impax Laboratories Company Information Table 110. Impax Laboratories Business Overview Table 111. Impax Laboratories Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Impax Laboratories Oxycodone Product Portfolio Table 113. Impax Laboratories Recent Development Table 114. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information Table 115. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview Table 116. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio Table 118. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development Table 119. Endo International Company Information Table 120. Endo International Business Overview Table 121. Endo International Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Endo International Oxycodone Product Portfolio Table 123. Endo International Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Oxycodone Distributors List Table 127. Oxycodone Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Oxycodone Product Image Figure 2. Global Oxycodone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Sales (2021-2032) & (k units) Figure 5. Global Oxycodone Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Oxycodone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Long Acting Oxycodone Image Figure 10. Short Acting Oxycodone Image Figure 11. Global Oxycodone Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Oxycodone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oxycodone Sales Volume Share by Type (2021-2032) Figure 14. Global Oxycodone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oxycodone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oxycodone Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Others Image Figure 20. Global Oxycodone Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Oxycodone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Oxycodone Sales Volume Share by Application (2021-2032) Figure 23. Global Oxycodone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Oxycodone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Oxycodone Sales Value Share by Application (2021-2032) Figure 26. Global Oxycodone Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Oxycodone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Oxycodone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Oxycodone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Oxycodone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Oxycodone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Oxycodone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Oxycodone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Oxycodone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Oxycodone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Oxycodone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Oxycodone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Oxycodone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Oxycodone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Oxycodone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Oxycodone
  • Short Acting Oxycodone
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Sun Pharmaceutical (Chattem Chemicals)
  • Sanofi
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Purdue Pharma
  • Mallinckrodt
  • Indivior
  • Impax Laboratories
  • Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oxycodone Sales Value (2021-2032)
  4. 1.2.2 Global Oxycodone Sales Volume (2021-2032)
  5. 1.2.3 Global Oxycodone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oxycodone Market Dynamics
  1. 2.1 Oxycodone Industry Trends
  2. 2.2 Oxycodone Industry Drivers
  3. 2.3 Oxycodone Industry Opportunities and Challenges
  4. 2.4 Oxycodone Industry Restraints
3 Oxycodone Market by Company
  1. 3.1 Global Oxycodone Company Revenue Ranking in 2025
  2. 3.2 Global Oxycodone Revenue by Company (2021-2026)
  3. 3.3 Global Oxycodone Sales Volume by Company (2021-2026)
  4. 3.4 Global Oxycodone Average Price by Company (2021-2026)
  5. 3.5 Global Oxycodone Company Ranking (2024-2026)
  6. 3.6 Global Oxycodone Company Manufacturing Base and Headquarters
  7. 3.7 Global Oxycodone Company Product Type and Application
  8. 3.8 Global Oxycodone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oxycodone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oxycodone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oxycodone Market by Type
  1. 4.1 Oxycodone Type Introduction
  2. 4.1.1 Long Acting Oxycodone
  3. 4.1.2 Short Acting Oxycodone
  4. 4.2 Global Oxycodone Sales Volume by Type
  5. 4.2.1 Global Oxycodone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oxycodone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oxycodone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oxycodone Sales Value by Type
  9. 4.3.1 Global Oxycodone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oxycodone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oxycodone Sales Value Share by Type (2021-2032)
5 Oxycodone Market by Application
  1. 5.1 Oxycodone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Oxycodone Sales Volume by Application
  6. 5.2.1 Global Oxycodone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oxycodone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Oxycodone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Oxycodone Sales Value by Application
  10. 5.3.1 Global Oxycodone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oxycodone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Oxycodone Sales Value Share by Application (2021-2032)
6 Oxycodone Regional Sales and Value Analysis
  1. 6.1 Global Oxycodone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxycodone Sales by Region (2021-2032)
  3. 6.2.1 Global Oxycodone Sales by Region: 2021-2026
  4. 6.2.2 Global Oxycodone Sales by Region (2027-2032)
  5. 6.3 Global Oxycodone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oxycodone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oxycodone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oxycodone Sales Value by Region (2027-2032)
  9. 6.5 Global Oxycodone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oxycodone Sales Value (2021-2032)
  12. 6.6.2 North America Oxycodone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oxycodone Sales Value (2021-2032)
  15. 6.7.2 Europe Oxycodone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oxycodone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oxycodone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oxycodone Sales Value (2021-2032)
  21. 6.9.2 South America Oxycodone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oxycodone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oxycodone Sales Value Share by Country, 2025 VS 2032
7 Oxycodone Country-level Sales and Value Analysis
  1. 7.1 Global Oxycodone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oxycodone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oxycodone Sales by Country (2021-2032)
  4. 7.3.1 Global Oxycodone Sales by Country (2021-2026)
  5. 7.3.2 Global Oxycodone Sales by Country (2027-2032)
  6. 7.4 Global Oxycodone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oxycodone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oxycodone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oxycodone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oxycodone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oxycodone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oxycodone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oxycodone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oxycodone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oxycodone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oxycodone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oxycodone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oxycodone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oxycodone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oxycodone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oxycodone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oxycodone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oxycodone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oxycodone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oxycodone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oxycodone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oxycodone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oxycodone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oxycodone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oxycodone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oxycodone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oxycodone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oxycodone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oxycodone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oxycodone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oxycodone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oxycodone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oxycodone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oxycodone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oxycodone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oxycodone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oxycodone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oxycodone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oxycodone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oxycodone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oxycodone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oxycodone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oxycodone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oxycodone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oxycodone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oxycodone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oxycodone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oxycodone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oxycodone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oxycodone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oxycodone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oxycodone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oxycodone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oxycodone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oxycodone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oxycodone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oxycodone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oxycodone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oxycodone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oxycodone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oxycodone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oxycodone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oxycodone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oxycodone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oxycodone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oxycodone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oxycodone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oxycodone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oxycodone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oxycodone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oxycodone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oxycodone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oxycodone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oxycodone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oxycodone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oxycodone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oxycodone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oxycodone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oxycodone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oxycodone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oxycodone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oxycodone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oxycodone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oxycodone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oxycodone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oxycodone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oxycodone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Oxycodone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Oxycodone Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Sun Pharmaceutical (Chattem Chemicals)
  8. 8.2.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
  9. 8.2.2 Sun Pharmaceutical (Chattem Chemicals) Business Overview
  10. 8.2.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
  12. 8.2.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oxycodone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oxycodone Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Oxycodone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Oxycodone Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Oxycodone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Oxycodone Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Oxycodone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Oxycodone Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Oxycodone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Oxycodone Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Mallinckrodt
  44. 8.8.1 Mallinckrodt Company Information
  45. 8.8.2 Mallinckrodt Business Overview
  46. 8.8.3 Mallinckrodt Oxycodone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mallinckrodt Oxycodone Product Portfolio
  48. 8.8.5 Mallinckrodt Recent Developments
  49. 8.9 Indivior
  50. 8.9.1 Indivior Company Information
  51. 8.9.2 Indivior Business Overview
  52. 8.9.3 Indivior Oxycodone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Indivior Oxycodone Product Portfolio
  54. 8.9.5 Indivior Recent Developments
  55. 8.10 Impax Laboratories
  56. 8.10.1 Impax Laboratories Company Information
  57. 8.10.2 Impax Laboratories Business Overview
  58. 8.10.3 Impax Laboratories Oxycodone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Impax Laboratories Oxycodone Product Portfolio
  60. 8.10.5 Impax Laboratories Recent Developments
  61. 8.11 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  62. 8.11.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
  63. 8.11.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
  64. 8.11.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments
  67. 8.12 Endo International
  68. 8.12.1 Endo International Company Information
  69. 8.12.2 Endo International Business Overview
  70. 8.12.3 Endo International Oxycodone Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Endo International Oxycodone Product Portfolio
  72. 8.12.5 Endo International Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxycodone Value Chain Analysis
  2. 9.1.1 Oxycodone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxycodone Sales Mode & Process
  6. 9.2 Oxycodone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxycodone Distributors
  9. 9.2.3 Oxycodone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst